# \[e-med\] Programme préqualification OMS: nouveaux appels à expression d'intérêt **URL:** \ **Category:** e-med\ **Created:** [July 11, 2007, 7:42am UTC](https://talk.edrugplus.org/t/e-med-programme-prequalification-oms-nouveaux-appels-a-expression-dinteret/28186 "2007-07-11T07:42:33Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![remed9](https://avatars.discourse-cdn.com/v4/letter/r/22d042/32.png) [@remed9](https://talk.edrugplus.org/u/remed9)\ **Post date:** [July 11, 2007, 7:42am UTC](https://talk.edrugplus.org/t/e-med-programme-prequalification-oms-nouveaux-appels-a-expression-dinteret/28186/1 "2007-07-11T07:42:33Z")
Bonjour, Sur e-drug, Angela Lopez du programme préqualification de l'OMS indique les adresses webs des nouveaux appels à expression d'intérêt destinés aux fabriquants d'ARV, d'antipaludiques et d'antituberculeux. Ils recouvrent des médicaments présents sur la dernière liste OMS des médicaments essentiels et/ou dans les guides thérapeutiques OMS. Elle vous demande de transmettre ce mail à tous les fabriquants potentiels de ces médicaments et de les encourager à se soumettre au système de préqualification de l'OMS. C'est à mon avis particulièrement important pour les antimalariques à base d'artésunate qui sont disponibles en ce moment sur le marché africain... Bonne journée à tous Carinne Bruneton ReMeD -----Message d'origine----- \ ] De la part de Everard@healthnet.org Envoyé : mardi 10 juillet 2007 15:31 Importance : Haute E-DRUG: New Invitations for Expression of Interest (EOIs) ------------------------------------------------- Dear friends and colleagues, The WHO Prequalification Programme would like to draw your attention to the 3 new Invitations for Expression of Interest (EOIs) recently published on its web site: - HIV [http://www.who.int/prequal/info\_applicants/eoi/EOI-HIVv7.pdf](http://www.who.int/prequal/info_applicants/eoi/EOI-HIVv7.pdf) - Malaria [http://www.who.int/prequal/info\_applicants/eoi/EOI-MalariaV5.pdf](http://www.who.int/prequal/info_applicants/eoi/EOI-MalariaV5.pdf) - TB [http://www.who.int/prequal/info\_applicants/eoi/EOI-TuberculosisV7.pdf](http://www.who.int/prequal/info_applicants/eoi/EOI-TuberculosisV7.pdf) The medicines listed in the current invitations have been identified by the respective WHO disease programmes and departments as vital to effective treatment for people living with HIV/AIDS, tuberculosis and malaria. These medicines are included either in the WHO Model List of Essential Medicines and/or in the respective WHO treatment guidelines, and thus can be considered as priority essential medicines. As compared with the previous Invitations, the lists have been updated by adding new therapeutic options, as supported by evidence. The new feature of the current lists is, that the recommended dosage forms and strengths for each medicine are described in order to guide manufacturers in product development and to support interchangebility of preparations for sustainable treatment and supply options. The procedure of submitting is also described in detail in the Invitations. The aim of publishing these new lists for prequalification is to increase the range of medicines and sources available in relation to treatment of HIV/AIDS, tuberculosis and malaria. Therefore, please distribute this information among potential manufacturers of the selected products, and encourage them to apply for prequalification of their products. With our best regards, Angela Angela M. F. Lopes Prequalification Programme Quality Assurance and Safety: Medicines World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Tel: +41 22 791 13 19 Fax:+41 22 791 47 30 e-mail: lopesa@who.int [http://www.who.int/prequal](http://www.who.int/prequal)